Bio Historical Income Statement
BIO Stock | USD 286.09 1.12 0.39% |
Historical analysis of Bio Rad income statement accounts such as Interest Expense of 51.9 M, Selling General Administrative of 481.6 M or Total Revenue of 1.4 B can show how well Bio Rad Laboratories performed in making a profits. Evaluating Bio Rad income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Bio Rad's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Bio Rad Laboratories latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Bio Rad Laboratories is a good buy for the upcoming year.
Bio |
About Bio Income Statement Analysis
Bio Rad Laboratories Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Bio Rad shareholders. The income statement also shows Bio investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Bio Rad Income Statement Chart
Bio Rad Laboratories Income Statement is one of the three primary financial statements used for reporting Bio's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Bio Rad Laboratories revenue and expense. Bio Rad Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Bio Rad's Non Operating Income Net Other is very stable compared to the past year. As of the 29th of May 2024, Non Recurring is likely to grow to about 353.2 M, while Selling General Administrative is likely to drop about 481.6 M. Add Fundamental
Total Revenue
Total revenue comprises all receipts Bio Rad Laboratories generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Bio Rad Laboratories minus its cost of goods sold. It is profit before Bio Rad operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Bio Rad Laboratories. It is also known as Bio Rad overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Net Income Applicable To Common Shares
The net income that remains after preferred dividends have been deducted, available to common shareholders.Most accounts from Bio Rad's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Bio Rad Laboratories current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. At this time, Bio Rad's Non Operating Income Net Other is very stable compared to the past year. As of the 29th of May 2024, Non Recurring is likely to grow to about 353.2 M, while Selling General Administrative is likely to drop about 481.6 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 1.6B | 1.6B | 1.4B | 769.3M | Total Revenue | 2.9B | 2.8B | 2.7B | 1.4B |
Bio Rad income statement Correlations
Click cells to compare fundamentals
Bio Rad Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Bio Rad income statement Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Depreciation And Amortization | 160.3M | 162.6M | 160.6M | 181.9M | 192.4M | 202.0M | |
Interest Expense | 23.4M | 21.9M | 1.6M | 38.1M | 49.4M | 51.9M | |
Selling General Administrative | 824.6M | 800.3M | 879.6M | 827.8M | 846.8M | 481.6M | |
Total Revenue | 2.3B | 2.5B | 2.9B | 2.8B | 2.7B | 1.4B | |
Gross Profit | 1.3B | 1.4B | 1.6B | 1.6B | 1.4B | 769.3M | |
Other Operating Expenses | 2.1B | 2.1B | 2.4B | 2.3B | 2.3B | 1.2B | |
Operating Income | 229.7M | 411.0M | 489.4M | 482.6M | 383.8M | 403.0M | |
Ebit | 229.7M | 411.0M | 489.4M | 482.6M | 383.8M | 403.0M | |
Ebitda | 390.0M | 573.6M | 650.0M | 664.5M | 576.2M | 605.0M | |
Cost Of Revenue | 1.1B | 1.1B | 1.3B | 1.2B | 1.2B | 1.3B | |
Total Operating Expenses | 1.0B | 1.0B | 1.2B | 1.1B | 1.0B | 613.7M | |
Income Before Tax | 2.3B | 4.9B | 5.4B | (4.7B) | (850.1M) | (807.6M) | |
Total Other Income Expense Net | 2.0B | 4.5B | 4.9B | (5.2B) | (1.2B) | (1.2B) | |
Net Income | 1.8B | 3.8B | 4.3B | (3.6B) | (637.3M) | (605.5M) | |
Income Tax Expense | 502.4M | 1.1B | 1.2B | (1.1B) | (212.8M) | (202.1M) | |
Research Development | 202.7M | 226.6M | 271.7M | 256.9M | 226.9M | 161.8M | |
Net Income Applicable To Common Shares | 1.8B | 3.8B | 4.2B | (3.6B) | (4.2B) | (4.0B) | |
Net Income From Continuing Ops | 1.8B | 3.8B | 4.2B | (3.6B) | (159.3M) | (151.3M) | |
Non Operating Income Net Other | 23.8M | 22.7M | 24.0M | 44.8M | 51.5M | 54.1M | |
Tax Provision | 502.4M | 1.1B | 1.2B | (1.1B) | (27.9M) | (26.5M) | |
Interest Income | 30.5M | 4.5B | 4.9B | 58M | 96.4M | 91.6M | |
Net Interest Income | 7.1M | (21.9M) | (1.6M) | 19.9M | 47.6M | 50.0M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bio Rad Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Complementary Tools for Bio Stock analysis
When running Bio Rad's price analysis, check to measure Bio Rad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio Rad is operating at the current time. Most of Bio Rad's value examination focuses on studying past and present price action to predict the probability of Bio Rad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio Rad's price. Additionally, you may evaluate how the addition of Bio Rad to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Bio Rad's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Rad. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Rad listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.797 | Earnings Share (10.68) | Revenue Per Share 90.024 | Quarterly Revenue Growth (0.1) | Return On Assets 0.0169 |
The market value of Bio Rad Laboratories is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Rad's value that differs from its market value or its book value, called intrinsic value, which is Bio Rad's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Rad's market value can be influenced by many factors that don't directly affect Bio Rad's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Rad's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Rad is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Rad's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.